COLUMBIA, Md.--(BUSINESS WIRE)--Celsion Corporation (NASDAQ: CLSN), a biotechnology drug development company that is leveraging its Heat Sensitive Liposomal Technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, today announced that President and CEO Michael H. Tardugno will present at BIO-Europe 2008 in Mannheim, Germany on November 18, 2008. This year marks BIO-Europe’s 14th Annual International Partnering Conference, with over 1,300 global companies represented. The presentation is scheduled to begin at 10:30 a.m. CET at the m:con Congress Center Rosengarten.
